Detected ·
Galvanize
$130MSeries D
Galvanize Therapeutics closed an oversubscribed $130M Series D, led by Sofinnova Partners' prior round, to expand its Aliya pulsed electric field platform and advance RheOx for chronic bronchitis.
- Website
- www.galvanizetx.com
- Amount
- $130 000 000 USD
- Stage
- Series D
- Event
- Funding round
- Detected
- 2026-11-16 20:09:27 UTC
- Signal ID
- b44c9536-3228-4c2a-b7e5-1a3c61f2c8c3
As the API returns it
{
"id": "b44c9536-3228-4c2a-b7e5-1a3c61f2c8c3",
"created_at": "2026-11-16T20:09:27.704812Z",
"company_name": "Galvanize",
"company_website_url": "www.galvanizetx.com",
"company_linkedin_url": "https://www.linkedin.com/company/galvanize-therapeutics",
"event_type": "funding",
"funding_amount": 130000000,
"funding_currency": "USD",
"funding_stage": "series_d",
"message": "*Galvanize Therapeutics closed an oversubscribed $130M Series D, led by Sofinnova Partners' prior round, to expand its Aliya pulsed electric field platform and advance RheOx for chronic bronchitis.*"
}